EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Paterson, Professor
National University of Singapore
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Malaya Medical Centre
Kuala Lumpur, Malaysia
Helmi Sulaiman, DrOng Hang Cheng, DrNot, yet, recruiting
- Taichung Veterans General Hospital
Taichung, Xitun District, Taiwan
Chien-Hao Tseng, DrPo-Yu Liu, DrRecruiting - Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Po-Liang Lu, ProfShang-yi Lin, DrYa-Ting Chang, DrNot, yet, recruiting
- Sunpasitthiprasong Hospital
Ubon Ratchathani, Thailand
Chamnan Parinya, DrSuwatthiya Kitsaran, DrNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Dec 2023
- Primary completion
- 31 Oct 2026
- Completion
- 31 Dec 2026
- Last update posted
- 6 Mar 2024
- Registered enrollment
- 1,900
- Registry id
- NCT05979545
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.